Kärppä M, Ning X, Galic M, et al, Reduction in the number of headache hours and days with fremanezumab in patients with migraine and documented inadequate response to 2-4 migraine preventive medications in the international, multicentre, randomised, placebo-controlled FOCUS study. 5th European Academy of Neurology (EAN) Congress, abstract EPO3096.
De invloed van vitamine D, roken en het Epstein-Barr-virus op cognitie bij MS
mei 2020 | Multipele Sclerose